Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Knott David M Jr
Form 13F · Q2 2026

Knott David M Jr

CIK 1892770Filed 2026-08-1213F-HR View the filing on EDGAR ↗
$189M
Reported book value
86
Positions
12
Quarters on record
Top 50
Positions

Knott David M Jr — holdings

Top 50 positions of 86, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1GOOG Alphabet Inc91,420+0.0%$32M17.1%
2APOLLO GLOBAL MGMT INC Apollo Global Mgmt Inc225,000+0.0%$27M14.1%
3SNDX Syndax Pharmaceuticals Inc437,245+3.6%$10M5.1%
4XERS Xeris Biopharma Holdings Inc1.1M+0.0%$8M4.4%
5TVTX Travere Therapeutics Inc147,282+4.7%$8M4.4%
6PTGX Protagonist Therapeutics Inc63,000+0.0%$8M4.1%
7BBIO Bridgebio Pharma Inc92,850+3.2%$7M3.7%
8IOVA Iovance Biotherapeutics Inc1.6M+0.0%$7M3.5%
9ALKS Alkermes Plc121,759+1.5%$6M3.4%
10JPM Jpmorgan Chase & Co18,098−7.1%$6M3.1%
11JANUS DETROIT STR TR Janus Detroit Str Tr93,528+0.0%$5M2.5%
12LPLA LPL Financial Holdings Inc.16,500+0.0%$5M2.5%
13COGT Cogent Biosciences Inc111,081+6.8%$4M2.3%
14TGTX Tg Therapeutics Inc66,839−25.7%$4M1.9%
15CLST Catalyst Bancorp Inc114,000—$4M1.9%
16AGIO Agios Pharmaceuticals Inc95,058+2.1%$4M1.9%
17VRDN Viridian Therapeutics Inc181,000+0.0%$3M1.8%
18RLMD Relmada Therapeutics Inc451,000+2.7%$3M1.6%
19RCUS Arcus Biosciences Inc81,241+0.0%$3M1.3%
20CYBIN INC Cybin Inc370,000+5.7%$2M1.3%
21SPDR SERIES TRUST Spdr Series Trust15,000+0.0%$2M1.3%
22RZLT Rezolute Inc370,000+0.0%$2M1.0%
23ALLIANCEBERNSTEIN HLDG L P Alliancebernstein Hldg L P48,000+0.0%$2M0.9%
24MDGL Madrigal Pharmaceuticals Inc3,000+50.0%$2M0.9%
25ATRC Atricure Inc51,400+0.0%$1M0.8%
26DCGO Docgo Inc2.7M+0.0%$1M0.7%
27ARDX Ardelyx Inc263,168+27.1%$1M0.7%
28RARE Ultragenyx Pharmaceutical In38,069+15.1%$1M0.7%
29SERIES PORTFOLIOS TR Series Portfolios Tr47,807+0.0%$1M0.7%
30CGEM Cullinan Therapeutics Inc69,182+185.9%$1M0.7%
31JNJ Johnson & Johnson4,922+0.0%$1M0.7%
32VERA Vera Therapeutics Inc26,000+0.0%$1M0.6%
33OBIO Orchestra Biomed Hldgs Inc253,651+0.0%$1M0.6%
34SPRB Spruce Biosciences Inc20,000—$1M0.6%
35CNTB Connect Biopharma Hldgs Ltd444,862+14.7%$1M0.6%
36ISHARES TR Ishares Tr5,500+0.0%$1M0.6%
37BIIB Biogen Inc4,000+0.0%$864,2400.5%
38PFE Pfizer Inc32,337+0.0%$778,6750.4%
39AAPL Apple Inc2,494+0.0%$721,6640.4%
40CANADIAN NAT RES LTD MED TER Canadian Nat Res Ltd Med Ter16,800+0.0%$663,6000.4%
41PTHS Pelthos Therapeutics Inc22,073+4.7%$623,7830.3%
42INTERNATIONAL BUSINESS MACHS International Business Machs2,142+0.0%$602,3520.3%
43MSFT Microsoft Corp1,600+0.0%$596,8320.3%
44VSTM Verastem Inc155,000+49.0%$592,1000.3%
45KURA Kura Oncology Inc52,767+0.0%$578,8540.3%
46SLDB Solid Biosciences Inc56,208+19.2%$561,5180.3%
47DD DuPont de Nemours, Inc.3,767—$510,9560.3%
48INSM Insmed Inc4,253—$453,4550.2%
49LBRX Lb Pharmaceuticals Inc12,965—$420,7790.2%
50CDNA Caredx Inc13,630—$388,4550.2%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.